vialroom

#cagrilintide 2026-06-08

Monday28 messages6 participantstimes are UTC
Highlights from this day
  • nadia_notes — did anyone find monotherapy underwhelming 20:58
  • two_three_lifts — weekly for me, same day every week, no reason beyond habit 22:24
  • verify_or_dont — unrelated but anyone dosing this on a different day to their tirzepatide 22:25
  • verify_or_dont — the nausea felt different rather than less, more fullness and less of the queasy wave 22:46
MM

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

amylin not glp-1

🧊11

5 in 3ml gives 2.5mg/ml which is what i use, purely because the units come out round

MM

i titrated over twice as many weeks as i did on semaglutide and that was right for me

different not less

MM

added it to an existing cagrilintide dose rather than starting both, which made attribution possible

MM

is anyone running this on its own or is it all CagriSema in here

went slower because the first step gave me two rough days and i took that as information

VO

the fullness thing is the part people describe differently, food stops being interesting rather than repellent

NN

combination GI was worse than either alone for me, which is not what i had read anywhere

cagrisema thats it

1📈13
TT

monotherapy was underwhelming for me and i say that as someone who wanted it to work

VO

CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it

cant separate them

VO

unrelated but anyone dosing this on a different day to their tirzepatide

Cited study
Efficacy and Safety of Cagrilintide in Adults with Overweight or Obesity — Phase 2
The Lancet · 2021
Cagrilintide monotherapy, dose ranging. The combination trials came later.
VO

the nausea felt different rather than less, more fullness and less of the queasy wave

📉1❤️118

how slow are people titrating this compared to retatrutide

i was sceptical about monotherapy and after 4 months im still sceptical, just less so